ClinVar Miner

Submissions for variant NM_004946.3(DOCK2):c.1316A>G (p.Asn439Ser)

gnomAD frequency: 0.00094  dbSNP: rs113673055
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000921680 SCV001067091 likely benign DOCK2 deficiency 2024-01-25 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003396548 SCV004120238 uncertain significance DOCK2-related condition 2023-06-16 criteria provided, single submitter clinical testing The DOCK2 c.1316A>G variant is predicted to result in the amino acid substitution p.Asn439Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.32% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-169129364-A-G). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.